Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × Bortezomib × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 25 Immunoglobulin Light-chain Amyloidosis 5 Paraproteinemias 2 Neoplasms, Plasma Cell 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Renal Insufficiency 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 HIV Infections 1 Anemia, Sickle Cell 1 Amyloidosis 1

Interventions

Azacitidine 7 venetoclax 6 Specimen Handling 6 Biopsy 6 Injections 5 Stem Cell Transplantation 4 Decitabine 4 Cytarabine 4 fludarabine 3 Cyclophosphamide 3 olutasidenib 2 fludarabine phosphate 2 decitabine and cedazuridine drug combination 2 cedazuridine 2 X-Rays 2 Whole-Body Irradiation 2 Vorinostat 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cyclosporins 2 Cyclosporine 2 Cladribine 2 Carboplatin 2 CPX-351 2 veliparib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡